These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 6339999

  • 1. [Clinical study of the efficacy of oral potassium canrenoate and spironolactone in essential arterial hypertension].
    Tosti-Croce C, Mantellini R, Fanti P, Sciarra F.
    Minerva Med; 1983 Apr 07; 74(14-15):791-7. PubMed ID: 6339999
    [Abstract] [Full Text] [Related]

  • 2. [Plasma renin activity in essential hypertension: different short- und long-term effects of diuretics (author's transl)].
    Esch I, Placheta P, Gaul G.
    Wien Klin Wochenschr; 1976 Jun 25; 88(13):415-8. PubMed ID: 824860
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Aldosterone-to-renin ratio, arterial stiffness, and the response to aldosterone antagonism in essential hypertension.
    Mahmud A, Feely J.
    Am J Hypertens; 2005 Jan 25; 18(1):50-5. PubMed ID: 15691617
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of potassium canrenoate on arterial pressure, plasma renin activity and urinary aldosterone in essential hypertension].
    Opocher G, Armanini D, Fallo F, Mantero F.
    Boll Soc Ital Cardiol; 1978 Jan 25; 23(10):1757-66. PubMed ID: 400390
    [No Abstract] [Full Text] [Related]

  • 7. Comparative clinical study of spironolactone and potassium canrenoate. A randomized evaluation with double cross-over.
    Emili M, Cuppone R, Ricci GL.
    Arzneimittelforschung; 1988 Oct 25; 38(10):1492-5. PubMed ID: 3058132
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
    Kreeft JH, Larochelle P, Ogilvie RI.
    Can Med Assoc J; 1983 Jan 01; 128(1):31-4. PubMed ID: 6336600
    [Abstract] [Full Text] [Related]

  • 11. Predicting interindividual variations in antihypertensive therapy: the role of sodium transport systems and renin.
    Niutta E, Cusi D, Colombo R, Pellizzoni M, Cesana B, Barlassina C, Soldati L, Bianchi G.
    J Hypertens Suppl; 1990 Sep 01; 8(4):S53-8. PubMed ID: 2175354
    [Abstract] [Full Text] [Related]

  • 12. Adaptation to chronic potassium loading in normal man.
    Hené RJ, Koomans HA, Boer P, Dorhout Mees EJ.
    Miner Electrolyte Metab; 1986 Sep 01; 12(3):165-72. PubMed ID: 3523191
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The effect of oral spironolactone and intravenous canrenoate-K on the digoxin radioimmunoassay.
    Lichey J, Schröder R, Rietbrock N.
    Int J Clin Pharmacol Biopharm; 1977 Dec 01; 15(12):557-9. PubMed ID: 598949
    [Abstract] [Full Text] [Related]

  • 15. [Controlled study of the effect of long-term administration of canrenoate potassium in cirrhotic ascites].
    Traina M, Vizzini GB.
    Minerva Med; 1986 Jan 28; 77(3-4):87-91. PubMed ID: 3511409
    [Abstract] [Full Text] [Related]

  • 16. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ, Taylor KP, Ashby MJ, Brown MJ.
    Circulation; 2007 Jul 17; 116(3):268-75. PubMed ID: 17606839
    [Abstract] [Full Text] [Related]

  • 17. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH, Reams GP, Wu Z, Lau-Sieckman A.
    J Hum Hypertens; 1995 Apr 17; 9(4):237-43. PubMed ID: 7595905
    [Abstract] [Full Text] [Related]

  • 18. [Saralasin in subjects with low renin arterial hypertension].
    Frisina N, Buemi M, Lasco A, Macrí I, Ciraolo O, Nicita Mauro V, Costa G.
    Boll Soc Ital Biol Sper; 1980 Jul 15; 56(13):1367-73. PubMed ID: 7004464
    [Abstract] [Full Text] [Related]

  • 19. [Double-blind therapeutic trial of spironolactone in arterial hypertension].
    Chávez-Domínguez R, Sánchez-Torres G, Serrano P.
    Arch Inst Cardiol Mex; 1975 Jul 15; 45(4):487-94. PubMed ID: 1101838
    [Abstract] [Full Text] [Related]

  • 20. Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites.
    Angeli P, Dalla Pria M, De Bei E, Albino G, Caregaro L, Merkel C, Ceolotto G, Gatta A.
    Hepatology; 1994 Jan 15; 19(1):72-9. PubMed ID: 8276370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.